Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Business Update

Venus Remedies Business Update

Venus Remedies Limited has disclosed links to social media posts regarding a special window for the re-lodgement of physical share transfer requests. This action follows SEBI guidelines to assist shareholders in converting physical holdings.

Source

BSE filing, NSE: VENUSREM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Venus Remedies Ltd: key numbers

Share price
₹1,300.50
Market cap
₹1,738 Cr
Revenue (annual)
₹769.6 Cr
Net profit (annual)
₹102.8 Cr
P/E (TTM)
14.3×Sector 45.9×
Promoter holding
41.76%+0.00% QoQ
FII holding
3.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Venus Remedies Ltd

All →
14:55 IST BSE
Regulatory Approval

Venus Remedies Regulatory Approval

Venus Remedies Limited secured five marketing authorizations for drugs including Vancomycin and Meropenem across Kazakhstan, Peru, Kuwait, and Argentina. These regulatory approvals expand its global pharmaceutical portfolio.

Other business update announcements

All →